Park Jong-Min, Jin Sung-Ho, Lee Sang-Rim, Kim Hong, Jung In Ho, Cho Yong Kwan, Han Sang-Uk
Department of Surgery, National Medical Center, Euljiro 6-ga, Jung-Gu, Seoul 100-799, Korea.
Surg Endosc. 2008 Oct;22(10):2133-9. doi: 10.1007/s00464-008-9962-4. Epub 2008 May 18.
Complications associated with laparoscopically assisted gastrectomy (LAG) are not significantly different from those associated with open gastrectomy. However, additional risks related to abdominal access, pneumoperitoneum, and special electrosurgical instruments result in an increased incidence of complications with LAG. This study analyzed the causes and risk factors linked to postoperative morbidity.
A retrospective review analyzed the data of 300 patients who underwent consecutive LAG for gastric cancer in our department from May 2003 to October 2006. Among the 300 patients, total gastrectomy was performed for 42 patients, distal gastrectomy for 258 patients, and proximal gastrectomy for 3 patients. The clinical and operative data obtained included body mass index, medical comorbidities, history of previous abdominal surgery, operative time, type of surgery, extent of lymph node dissection according to the Japanese Guideline, number of retrieved lymph nodes and lymph node metastases, additional operative procedure, depth of tumor invasion, and disease stage. The outcome data consisted of mortality, major morbidities, and postoperative hospital stay. The 300 cases were divided into two periods: 50 cases in the first period and 250 cases in the second period.
Postoperative complications developed in 61 cases (20.3%), wound infection in 21 cases (7%), intraabdominal abscess in 3 cases (1%), bleeding in 12 cases (4%), stenosis in 13 cases (4.3%), leakage in 3 cases (1%), acute pancreatitis in 2 cases (0.7%), pulmonary complication in 4 cases (1.3%), renal complication in 4 cases (1.3%), and cardiac complication in 2 cases (0.7%). The 30-day mortality rate was 0.7% (n=2). Univariate analysis proved that gender, operative period, comorbidity, and operative times were important risk factors. Multivariate analysis proved that cormobidity and operative period were important risk factors.
The data suggest that LAG can be performed with acceptable perioperative complication rates. The surgeon's experience and careful patient selection determined optimal patient outcomes.
腹腔镜辅助胃切除术(LAG)相关并发症与开腹胃切除术相关并发症并无显著差异。然而,与腹部入路、气腹和特殊电外科器械相关的额外风险导致LAG并发症发生率增加。本研究分析了与术后发病相关的原因和危险因素。
一项回顾性研究分析了2003年5月至2006年10月在我科连续接受LAG治疗胃癌的300例患者的数据。在这300例患者中,42例行全胃切除术,258例行远端胃切除术,3例行近端胃切除术。获得的临床和手术数据包括体重指数、合并症、既往腹部手术史、手术时间、手术类型、根据日本指南的淋巴结清扫范围、回收淋巴结数量和淋巴结转移情况、附加手术操作、肿瘤浸润深度和疾病分期。结果数据包括死亡率、主要并发症和术后住院时间。300例患者分为两个时期:第一期50例,第二期250例。
61例(20.3%)发生术后并发症,21例(7%)发生伤口感染,3例(1%)发生腹腔内脓肿,12例(4%)发生出血,13例(4.3%)发生狭窄,3例(1%)发生渗漏,2例(0.7%)发生急性胰腺炎,4例(1.3%)发生肺部并发症,4例(1.3%)发生肾脏并发症,2例(0.7%)发生心脏并发症。30天死亡率为0.7%(n = 2)。单因素分析证明性别、手术时期、合并症和手术次数是重要危险因素。多因素分析证明合并症和手术时期是重要危险因素。
数据表明LAG可以在可接受的围手术期并发症发生率下进行。外科医生的经验和仔细的患者选择决定了最佳的患者预后。